2024
Seidler D, Winter L, Karlíková M, Topolčan O, Steiger K, Nováková K,
Burkhardt R, Niedermair T, Brochhausen C. Bridging Financial Challenges in Young
Biobanks-Funding Strategies from the Central Biobank Regensburg. Biopreserv
Biobank. 2024 Dec 12. doi: 10.1089/bio.2023.0129. Epub ahead of print. PMID:
39667747.
Polivka J, Gouda MA, Sharif M, Pesta M, Huang H, Treskova I, Woznica V,
Windrichova J, Houfkova K, Kucera R, Fikrle T, Ricar J, Pivovarcikova K,
Topolcan O, Janku F. Predictive Significance of Combined Plasmatic Detection of
BRAF Mutations and S100B Tumor Marker in Early-Stage Malignant Melanoma. Cancer
Med. 2024 Oct;13(19):e70313. doi: 10.1002/cam4.70313. PMID: 39387479; PMCID:
PMC11465285.
Pesta M, Travnicek I, Kulda V, Ostasov P, Windrichova J, Houfkova K, Knizkova
T, Bendova B, Hes O, Hora M, Topolcan O, Polivka J. Prognostic Value of Tumor
Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC). In
Vivo. 2024 Jul-Aug;38(4):1799-1805. doi: 10.21873/invivo.13631. PMID: 38936941;
PMCID: PMC11215600.
Karlíková M, Čurillová M, Pecen L, Karnos V Jr, Karnos V, Topolčan O.
Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as
Cancer Biomarkers in Colorectal Cancer. Anticancer Res. 2024
Jul;44(7):3105-3113. doi: 10.21873/anticanres.17124. PMID: 38925804.
Simanek V, Dedeckova E, Topolcan O, Kralova M, Kucera R. A Case Study of
Vitamin D Supplementation Therapy and Acute Respiratory Tract Infection. In
Vivo. 2024 Mar-Apr;38(2):949-953. doi: 10.21873/invivo.13525. PMID: 38418127;
PMCID: PMC10905438.
Šimánek V, Vrzáková R, Viták R, Jirásko M, Fürst T, Topolčan O, Pecen L, Vurm
V, Kučera R. Preanalytical stability of molecular forms of prostate-specific
antigen in serum samples (PSA, free PSA, [-2]proPSA) and their impact on
fPSA/tPSA ratio and PHI. Prostate. 2024 May;84(7):656-665. doi:
10.1002/pros.24681. Epub 2024 Feb 27. PMID: 38414098.
Fiala O, Hošek P, Korunková H, Hora M, Kolář J, Šorejs O, Topolčan O,
Filipovský J, Liška V, Santoni M, Buti S, Fínek J. Concomitant antihypertensive
medication and outcome of patients with metastatic castration-resistant prostate
cancer receiving enzalutamide or abiraterone acetate. Cancer Med. 2024
Jan;13(1):e6853. doi: 10.1002/cam4.6853. Epub 2024 Jan 2. PMID: 38164124; PMCID:
PMC10807645.
2023
Vrzáková R, Šimánek V, Topolčan O, Vurm V, Slouka D, Kučera R. The Stability
of the Anti-Müllerian Hormone in Serum and Plasma Samples under Various
Preanalytical Conditions. Diagnostics (Basel). 2023 Apr 21;13(8):1501. doi:
10.3390/diagnostics13081501. PMID: 37189609; PMCID: PMC10137981.
Ramakrishnan V, Schönmehl R, Artinger A, Winter L, Böck H, Schreml S, Gürtler
F, Daza J, Schmitt VH, Mamilos A, Arbelaez P, Teufel A, Niedermair T, Topolcan
O, Karlíková M, Sossalla S, Wiedenroth CB, Rupp M, Brochhausen C. 3D
Visualization, Skeletonization and Branching Analysis of Blood Vessels in
Angiogenesis. Int J Mol Sci. 2023 Apr 23;24(9):7714. doi: 10.3390/ijms24097714.
PMID: 37175421; PMCID: PMC10178731.
Dědečková E, Viták R, Jirásko M, Králová M, Topolčan O, Pecen L, Fürst T,
Brož P, Kučera R. Vitamin D<sub>3</sub> Supplementation: Comparison of 1000 IU
and 2000 IU Dose in Healthy Individuals. Life (Basel). 2023 Mar 16;13(3):808.
doi: 10.3390/life13030808. PMID: 36983963; PMCID: PMC10053989.
Ferda J, Hes O, Hora M, Ferdová E, Pernický J, Rudnev V, Pecen L, Topolčan O,
Mírka H. Assessment of Prostate Carcinoma Aggressiveness: Relation to
<sup>68</sup>Ga-PSMA-11-PET/MRI and Gleason Score. Anticancer Res. 2023
Jan;43(1):449-453. doi: 10.21873/anticanres.16181. PMID: 36585198.
Fiala O, Hosek P, Korunkova H, Hora M, Kolar J, Windrichova J, Sorejs O,
Topolcan O, Travnicek I, Sedlackova H, Finek J. Enzalutamide or Abiraterone
Acetate With Prednisone in the Treatment of Metastatic Castration-resistant
Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution
Experience. Anticancer Res. 2023 Jan;43(1):463-471. doi:
10.21873/anticanres.16183. PMID: 36585174.
Seidler D, Karlíková M, Topolčan O, Snítilá M, Niedermair T, Brochhausen C.
Establishing Biobanking in Medical Curricula-The Education Program "Precision
Medicine International" (eduBRoTHER). Biopreserv Biobank. 2023
Apr;21(2):200-207. doi: 10.1089/bio.2022.0088. Epub 2022 Nov 11. PMID: 36367703;
PMCID: PMC10125393.
2022
Polivka J, Svajdler M, Priban V, Mracek J, Kasik P, Martinek P, Ptakova N,
Sharif Bagheri M, Shetti D, Pesta M, Potuznik P, Topolcan O. Oncogenic Fusions
in Gliomas: An Institutional Experience. Anticancer Res. 2022
Apr;42(4):1933-1939. doi: 10.21873/anticanres.15671. PMID: 35347013.
Reischig T, Kacer M, Vlas T, Drenko P, Kielberger L, Machova J, Topolcan O,
Kucera R, Kormunda S. Insufficient response to mRNA SARS-CoV-2 vaccine and high
incidence of severe COVID-19 in kidney transplant recipients during pandemic. Am
J Transplant. 2022 Mar;22(3):801-812. doi: 10.1111/ajt.16902. Epub 2021 Dec 10.
PMID: 34860470; PMCID: PMC9906453.
Mayer O Jr, Bruthans J, Seidlerová J, Gelžinský J, Kučera R, Karnosová P,
Mateřánková M, Wohlfahrt P, Cífková R, Filipovský J. High leptin status
indicates an increased risk of mortality and heart failure in stable coronary
artery disease. Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2137-2146. doi:
10.1016/j.numecd.2022.06.006. Epub 2022 Jun 16. PMID: 35843790.
Wolrab D, Jirásko R, Cífková E, Höring M, Mei D, Chocholoušková M, Peterka O,
Idkowiak J, Hrnčiarová T, Kuchař L, Ahrends R, Brumarová R, Friedecký D, Vivo-
Truyols G, Škrha P, Škrha J, Kučera R, Melichar B, Liebisch G, Burkhardt R, Wenk
MR, Cazenave-Gassiot A, Karásek P, Novotný I, Greplová K, Hrstka R, Holčapek M.
Lipidomic profiling of human serum enables detection of pancreatic cancer. Nat
Commun. 2022 Jan 10;13(1):124. doi: 10.1038/s41467-021-27765-9. PMID: 35013261;
PMCID: PMC8748654.